Exhibit 10.7
AMENDMENT NUMBER ONE TO CLINICAL
TRIAL AGREEMENT
THIS AMENDMENT NUMBER ONE TO THE
CLINICAL TRIAL AGREEMENT (the “Amendment”) is effective
14 October 2009 (“Effective Date”) The General
Hospital Corporation d/b/a Massachusetts General Hospital, a
not-for-profit corporation organized under the laws of
Massachusetts with its principal place of business at 55 Fruit
Street, Boston, MA 02114 (“Institution”) and CytoDyn,
Inc., a publicly traded corporation organized under the laws of
Colorado with its principal place of business at 1511 Third Street,
Santa Fe, New Mexico 87505 (“Company”).
RECITALS
|
|
A.
|
INSTITUTION has
previously entered into a Clinical Trial Agreement to perform the
study protocol entitled “An observational study to
determine th
|